200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 538-58-9
538-58-9 | 1,5-Diphenylpenta-1,4-dien-3-one
CAS No: 538-58-9 Catalog No: AG0032NB MDL No:MFCD00004790
Product Description
Catalog Number:
AG0032NB
Chemical Name:
1,5-Diphenylpenta-1,4-dien-3-one
CAS Number:
538-58-9
Molecular Formula:
C17H14O
Molecular Weight:
234.2925
MDL Number:
MFCD00004790
IUPAC Name:
(1E,4E)-1,5-diphenylpenta-1,4-dien-3-one
InChI:
InChI=1S/C17H14O/c18-17(13-11-15-7-3-1-4-8-15)14-12-16-9-5-2-6-10-16/h1-14H/b13-11+,14-12+
InChI Key:
WMKGGPCROCCUDY-PHEQNACWSA-N
SMILES:
O=C(/C=C/c1ccccc1)/C=C/c1ccccc1
UNII:
9QXO7BCY9L
NSC Number:
623642
Properties
Complexity:
272
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
2
Exact Mass:
234.104g/mol
Formal Charge:
0
Heavy Atom Count:
18
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
234.298g/mol
Monoisotopic Mass:
234.104g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
17.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.1
Literature
| Title | Journal |
|---|---|
| Effects of curcumin and related compounds on processes involving α-hydroxyethyl radicals. | Free radical research 20120301 |
| Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. | Biochemical pharmacology 20111215 |
| Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors. | Bioorganic & medicinal chemistry letters 20110515 |
| Cu(I) complexes containing a multidentate and conformationally flexible dibenzylidene acetone ligand (dbathiophos): application in catalytic alkene cyclopropanation. | Dalton transactions (Cambridge, England : 2003) 20110414 |
| Synthesis and structure-affinity relationships of novel dibenzylideneacetone derivatives as probes for β-amyloid plaques. | Journal of medicinal chemistry 20110414 |
| ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins. | Cancer research 20110115 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| pi-Acidic alkene ligand effects in Pd-catalysed cross-coupling processes: exploiting the interaction of dibenzylidene acetone (dba) and related ligands with Pd(0) and Pd(II). | Organic & biomolecular chemistry 20081021 |
| Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues. | European journal of medicinal chemistry 20080801 |
| Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans. | European journal of medicinal chemistry 20070101 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin. | Bioorganic & medicinal chemistry letters 20030106 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.